Loading company…
Founded in 2001 and based in Hong Kong, SinoMab Bioscience Limited develops and markets immunotherapies for rheumatoid arthritis.
Founded in 2001 and based in Hong Kong SAR, China, SinoMab Bioscience Limited researches, develops, manufactures and markets immunotherapies for treating rheumatoid arthritis. The company is at the Late stage and is classified under biotechnology.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in